Primary Central Nervous System Vasculitis: From Diagnosis to Management
Primary central nervous system vasculitis is an important but rare differential diagnosis in daily neurological practice, warranting the need of a step by step approach.
All articles by Amit Akirov, MD
Amyotrophic Lateral Sclerosis Prevention: Neurodegenerative Diseases Offer Insight
Researchers sought to develop a “roadmap” to early intervention and disease prevention for ALS by observing advances in neurodegenerative diseases with a presymptomatic period.
No Overall Benefit of Early Anticoagulant Therapy for Ischemic Stroke
In a Cochrane Review update, researchers sought to assess the effectiveness and safety of early anticoagulation for people with acute presumed or confirmed ischemic stroke.
Prognosis Discordant Common Between Families, Physicians in Severe Brain Injury
In a cross-sectional study, researchers sought to better understand prognosis discordance between physicians and families with patients with severe brain injury and the factors associated with it.
Updated Guidelines on the Role of MRI in Multiple Sclerosis
Presenting at the CSMC 2021, researchers highlighted the international consensus 2021 revisions to the guidelines on MRI in multiple sclerosis (MS), merging recommendations from 3 MS groups.
Inosine Fails to Slow Early Parkinson Disease Progression in Phase 3 Trial
Researchers assessed the impact of oral inosine, a metabolic precursor of urate, on disease progression in patients with early Parkinson disease.
Treatment Response to Zolpidem in Patients With Insomnia: The Importance of Priming
Researchers assessed whether zolpidem (priming) is required for partial reinforcement or whether intermittent dosing with placebos can be effective for acute and extended treatment for patients with chronic insomnia.
Does Anakinra Have a Role in the Treatment of Severe COVID-19?
Authors of a commentary assessed the role of IL-1 receptor antagonism, specifically anakinra, in the treatment of patients with severe COVID-19.
FIREFISH Trial Shows Risdiplam Benefits in Infants With Type 1 Spinal Muscular Atrophy
Researchers evaluated the safety and efficacy of risdiplam in infants with type 1 spinal muscular atrophy compared with historical cohorts.
Outcomes of a Neurology Career Development Program for Underrepresented Minorities and People with Disabilities
A neurology career advancement program for people underrepresented in medicine may help early career individuals enter and remain in mainstream neurologic research and academic neurology.
- Loading...
Loading...
Loading... 
Loading...